154 results
8-K
EX-99.1
az8xsggvl6qh mz2bq
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
8-K
EX-10.1
99vv q6jp4lvrzzo7jxx
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.1
3jwo4p36v3 vm
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm